S. Korea Study Finds No Added Pregnancy Risk From Antibiotics, Tylenol
This article was originally published in PharmAsia News
Executive Summary
A South Korean study has concluded that taking antibiotics and painkillers in the early stages of pregnancy has almost no effect on the risk of having a deformed child. A team of scientists studied pregnant women exposed to ampicillin and Ortho McNeill Jansen's Tylenol (acetaminophen) between 3.5 and 4.6 weeks of pregnancy and compared outcomes with unexposed mothers-to-be and found no statistically differences between the two groups in giving birth to congenitally malformed offspring. The same study also found the dosages did not create a statistically different risk of premature births, underweight children or miscarriages. (Click here for more
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.